Drug Solutions Podcast: Starting Up in the CGT Manufacturing Space
In this episode of the Drug Solutions Podcast, Shawn Liu, the president and CEO of Avirmax, relates his experience in entering the cell and gene therapy manufacturing space and how he began his own startup cell and gene therapy CDMO.
In this episode of the Drug Solutions Podcast, Shawn Liu, the president and CEO of Avirmax, relates his experience in entering the cell and gene therapy (CGT) manufacturing space and how he began his own startup cell and gene therapy CDMO. He discusses the challenges of establishing his company’s own CGT manufacturing facility and points out the pitfalls and what to avoid when starting up a business in this space.
Sponsor
About the speaker
Shengjiang (Shawn) Liu is president and CEO of Avirmax. He has 40 years of experience in virology and 28 years’ experience in biotechnology. He has entrepreneurial experience in life sciences and in biologics and business development. He has a strong research background and earned his PhD with a focus in Biochemistry from Kansas State University.
About the Drug Solutions Podcast
Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
